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Abstract
Objective: Given the trends in aging worldwide, in Mexico, we determined trends in adjusted mortality rates due
to cancer and 11 cancer subtypes in older individuals (>65 years) from 2000 to 2010.
Methods: For this retrospective study, we collected data on mortality due to cancer from the registries of the
National Institute of Statistics and Geography. Adjusted rates were calculated with a direct method based on the
world standard population. Trend analysis was performed with a linear regression of the natural logarithm of the
adjusted rate, and trends were evaluated with the Student´s t test.
Results: During the studied period, the cancer mortality rates significantly declined from 630.21 to 573.03 (per
100,000 inhabitants) in the overall population. Similar declines were observed in women (from 548.81 to 490.09)
and men (from 726.03 to 672.94). Significant declines in mortality rates were observed across several cancer
subtypes, including esophageal, gastric, colorectal-anal, liver-biliary, pancreatic, and tracheal-bronchial-lung
cancers. Significant increases in mortality rates were observed in colorectal and breast cancer, but no changes were
observed in mortality rates due to prostate, ovarian, bladder, and non-Hodgkin lymphoma cancers.
Conclusion: Mortality due to cancer in older Mexicans was lower than that observed in developed countries, and
it significantly declined over the study period. Men had higher mortality rates than women. The highest mortality
rates were due to breast and prostate cancer subtypes in older individuals.
Introduction
After cardiovascular disorders, cancer is the second leading cause of
death in the world [1]. It affects both genders, and its economic impact
is greater than any other cause of death in the world. The total
economic impact of premature death and disability from cancer
worldwide was $895 billion in 2008. This data represents 1.5% of the
world’s gross domestic product [2]. Among the risk factors for cancer,
age is one of the most important; cancer incidence and cancer-related
mortality rises exponentially after 50 years of age [3].
Due to increases in birth rate and life expectancy, the number of
older individuals is currently increasing around the world. With this
trend, the prevalence of cancer is likely to rise. This fact has important
implications for the implementation of preventive strategies and
treatment for cancer in older age groups. In older individuals, some
cancers may be more aggressive or more indolent than in younger
adult age groups [3].
On the other hand, Mexico is considered a country of young people.
However, like other countries, Mexico has experienced considerable
growth in its population, both in life expectancy and in the number of
individuals. Thus, we might expect modifications in the incidence and
mortality of some diseases, such as cancer, in the future. Hence,
surveillance is important to ensure correct allocations of economic and
human resources. Given the importance of cancer in public health,
and due to the few studies that have focused on this older segment of
the population, the present study aimed to determine recent trends in
cancer among older individuals in Mexico from 2000 to 2010.
Methods
In this observational, retrospective study, we collected information
on death due to cancer in individuals ≥ 65 years old from the database
of the National Institute of Statistics and Geography (INEGI in
Spanish) [4]. In this database, deaths that occurred from the years
2000 to 2010 were grouped according to the International
Classification of Disease, version 10 (ICD-10). For the current analysis,
we stratified deaths by gender, age group, and 11 cancer subtypes. The
age groups were: 65–69, 70–74, 75–79, 80–84, and > 85 years. The
cancer subtypes were: esophageal, stomach, colorectal, liver,
pancreatic, tracheobronchial, bladder, non-Hodgkin lymphoma,
prostate, cervical, and ovarian cancers.
Analyses
Standardized rates of mortality (per 100,000 inhabitants) were
calculated with the direct method, using the world standard
population. The populations used in the denominators of the 2000,
2005, and 2010 mortality rates were taken from the corresponding
census estimates. For the other years, the denominators were
estimated by linear interpolation. Trend analysis was performed with a
linear regression of the natural logarithm of the adjusted rate, and the
trends were evaluated with the Student´s t test. For the annual
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percentage change (APC), we used the following formula:
APC=(em-1)*100, where em was the antilogarithm of the slope
previously calculated with linear regression. MINITAB 16 and EXCEL
were used to perform the analyses.
Ethical considerations
This study was based on freely available data at www.inegi.org.mx.
In this public domain database, the identity, preferences, and other
data of deceased individuals are maintained strictly confidential.
Results
During the period studied, a total of 392,081 deaths due to cancer
occurred in individuals aged >65 years in Mexico. This represented
13.5% of all deaths in this particular age group. According to gender,
cancer was responsible for 14.6% and 12.4% of all deaths in elderly
man and women respectively. The average mortality due to cancer was
603.92/100,000 inhabitants. This rate significantly decreased over the
study period, from 630.21 to 573.03 (per 100,000 inhabitants), with an
APC of -1.05%. Men had higher mortality rates than women; the male/
female ratio was 1.35. Despite the different magnitudes, both genders
exhibited a significant decrease in mortality rates over time. In men,
mortality decreased from 726.03 to 672.94 (per 100,000 inhabitants),
with an APC of -0.91%; in women, it decreased from 548.81 to 490.09
(per 100,000 inhabitants), with an APC of -1.18% (Table 1). With the
exception of individuals >85 years old, all age groups studied exhibited
a significant decrease in mortality rates over time. The highest APC
was -1.46% in the 65-69 year-old age group; the lowest APC was -0.377
in the 75 – 79 year-old age group.
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 APC P
Gender              
Overall 630.21 623.7 624.76 624.49 613.53 612.53 596.77 588 582.1 573.94 573.03 -1.05 0
Male 726.03 717.31 730.86 727.69 714.7 718.21 694.57 685.88 684.6 670.07 672.94 -0.91 0
Female 548.81 543.6 534.22 537.3 528.09 523.76 514.67 506.1 496.72 494.08 490.09 -1.18 0
Age              
*65-69 yrs 413.3 398.2 403.55 401.87 387.6 377.21 379.57 369.98 362.4 365.99 353.95 -1.459 0
*70-74 yrs 574.15 575.75 564.23 562.28 550.02 556.96 525.46 517.12 506.55 487.74 488.92 -1.804 0
*75-79 yrs 750.29 756.09 761.33 748.85 736.78 743.48 728.2 726.5 740.52 734.63 728.79 -0.378 0
*80-84 yrs 971.12 945.61 983.67 1000.24 984.76 979.28 946.75 926.19 912.73 880.02 889.93 -1.035 0
*> 85 yrs 1060.43 1063.47 1025.35 1042.61 1060.74 1063.87 1041.19 1034.82 1016.16 1020.05 1060.01 -0.209 0.233
APC: Annual Percentage Change, *= Crude rates
Table 1: Cancer mortality trends in older Mexican individuals (>65 years) according gender and age (rates are per 100,000 inhabitants)
The cancer subtypes that caused the highest mortality rates during
the studied period were tracheobronchial, followed by stomach and
liver cancers. The mortality rates due to these subtypes significantly
decreased over time, with APCs of −5.35%, −3.16%, and −0.86%,
respectively. On the other hand, only the mortality rate due to
colorectal cancer showed a significant increase over the study period,
with an APC of 0.67%. Mortality rates due to bladder cancer and non-
Hodgkin lymphoma did not change over the study period (Table 2).
In men, the highest mortality was due to tracheobronchial cancer,
followed by prostate and stomach cancers. Of these, only deaths due to
tracheobronchial and stomach cancers showed a significant decreases
over time, with APCs of -3.39% and 2.88%, respectively. Mortality due
to colorectal cancer showed a significant increase over time, with an
APC of 1.48%. No changes over time were observed in mortality due
to esophageal, prostate, bladder, and non-Hodgkin lymphoma cancers
(Table 2).
In women, the highest mortality rates were due to cervical, liver,
and tracheobronchial cancers. Only mortality due to breast cancer
showed a significant increase over time, with an APC of 0.94%. No
changes over time were observed in mortality rates due to colorectal,
ovarian, bladder, and non-Hodgkin lymphoma cancers (Table 2).
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 APC P
Overall
Esophagus 10.11 9.40 9.54 10.82 8.85 9.22 9.47 9.44 8.81 8.19 8.67 -1.59 0.016
Stomach 61.58 58.41 57.83 57.28 54.55 53.41 51.99 48.04 47.19 45.77 45.19 -3.16 0.000
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colon, rectum,
anus
29.96 30.67 29.07 30.84 31.00 32.18 31.69 32.45 33.19 30.71 31.26 0.67 0.052
Liver, bile duct 54.57 53.40 54.56 56.32 56.39 54.08 54.60 49.98 50.89 51.96 50.85 -0.86 0.020
Pancreas 35.14 35.02 34.98 33.02 34.82 34.49 33.53 33.47 34.12 32.95 31.86 -0.74 0.005
Lung, brochi
trachea.
86.93 85.21 86.19 83.61 83.38 82.28 76.02 72.27 69.95 66.55 64.94 -3.09 0.000
Bladder 9.60 9.84 9.31 8.82 9.21 9.05 10.05 11.42 10.81 9.53 9.10 0.59 0.456
Non Hodgkin
Lymphoma
13.84 13.51 15.52 14.33 14.41 15.53 15.29 14.71 14.34 15.15 14.97 0.66 0.140
Male 
Esophagus 15.20 14.10 14.32 16.43 13.78 14.50 15.25 14.51 14.10 13.10 13.03 -1.13 0.071
Stomach 72.85 68.38 68.11 67.34 63.68 61.27 61.63 56.65 55.86 55.38 54.96 -2.88 0.000
Colon, rectum,
anus
31.91 31.47 29.98 30.64 31.97 34.23 33.92 33.77 35.69 34.05 35.46 1.48 0.001
Liver, bile duct 55.28 53.56 57.53 57.53 57.68 55.85 55.72 52.18 52.01 53.57 52.51 -0.72 0.054
Pancreas 34.79 34.67 34.74 32.38 34.58 33.66 32.71 33.13 34.61 32.30 30.19 -0.92 0.020
Lung, bronchi ,
trachea
129.09 127.85 129.57 124.57 124.06 123.97 113.19 106.37 103.12 96.67 94.06 -3.39 0.000
Prostate 149.22 151.29 152.57 160.54 150.97 155.65 145.66 149.01 147.61 144.87 147.24 -0.48 0.097
Bladder 13.56 14.54 12.73 12.87 12.74 13.42 14.63 14.70 14.91 13.45 13.80 0.59 0.321
Non Hodgkin
Lynphoma
15.62 14.41 17.17 14.93 17.38 17.52 16.88 16.65 16.69 17.55 16.92 1.18 0.059
Female 
Esophagus 5.73 5.35 5.40 5.97 4.62 4.72 4.51 5.04 4.28 3.97 4.95 -2.67 0.013
Stomach 51.79 49.66 48.82 48.46 46.62 46.69 43.68 40.64 39.69 37.48 36.80 -3.46 0.000
colon, rectum,
anus
28.11 29.88 28.14 30.89 30.04 30.38 29.74 31.23 31.01 27.80 27.58 -0.07 0.879
Liver, bile duct 54.04 53.16 52.00 55.33 55.26 52.57 53.58 48.11 50.05 50.65 49.48 -0.96 0.018
Pancreas 35.40 35.25 35.16 33.56 34.94 35.17 34.25 33.75 33.67 33.41 33.28 -0.60 0.002
Lung, bronchi,
trachea.
50.29 48.23 48.58 48.20 48.26 46.26 44.08 43.08 41.70 40.91 40.10 -2.30 0.000
Breast 40.58 40.74 42.09 43.17 42.69 42.08 43.15 43.38 43.71 44.08 45.67 0.94 0.000
Cervical 65.34 61.19 57.26 56.58 53.74 51.81 47.10 46.34 44.58 43.45 39.40 -4.60 0.000
ovary 17.54 17.61 18.68 18.27 18.75 18.69 19.35 19.67 18.40 18.60 18.26 0.50 0.130
Bladder 6.20 5.82 6.37 5.38 6.19 5.37 6.21 8.69 7.34 6.21 5.20 0.69 0.648
Non Hodgkin
Lynphoma
12.27 12.73 14.06 13.84 11.83 13.85 13.94 12.97 12.35 13.10 13.32 0.15 0.802
APC: Annual Percentage Change
Table 2: Cancer mortality trends in older Mexican (>65 years) according cancer subtype (rates are per 100,000 inhabitants)
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Discussion
This study determined the recent trends in mortality due to cancer
in older Mexican individuals, which included individuals >65 years of
age. Our results indicated that mortality rates were much lower than
those reported in other countries, including the United States, Japan,
and Italy [5-7]. A relatively low rate has been also observed in younger
Mexican individuals [8]. The reasons for these world differences, to
date, remain unclear, but genetic and environmental factors may be
involved. The male predominance we observed was consistent with
other studies [9]. This predominance may be explained by hormonal
factors and the prevalence of unhealthy behaviors among men, such as
smoking and drinking alcohol [10].
We observed decreased cancer-related mortality rates over time in
four out of five of the age groups studied, but not in people >85 years
old (Table 1). With respect to this last age group, an Italian study [7]
has reported significant decreases in their mortality rates while an
USA [11] study has reported significant increases in the proportion of
cancer deaths (cancer deaths in oldest old/cancer deaths in all ages).
The decrease in mortality rates of those 65–84 years might be
explained by increased adoption of preventative practices, like early
detection of precancerous lesions, and by improvements in treating
some cancer subtypes in Mexico. Although the mortality rates due to
tracheobronchial-lung cancer were highest in the overall population,
the mortality due to these cancer subtypes also showed the greatest
decrease over time. This might be explained, in part, by an increasing
number of individuals that quit smoking in the general population. On
the other hand, the significant increase over time in mortality rates
due to colorectal-anal cancer suggested a Westernization of nutritional
habits and life style among Mexicans [12].
As in others countries, the highest mortality in Mexico among the
older population men was due to prostate cancer. Furthermore,
mortality due to this subtype did not show any change in over time.
Previously, it has been observed increases in crude rates of mortality in
overall Mexican men [13], but studies in 65 years-old men are lacking
in México. The study design did not allow us to determine whether the
incidence in prostate cancer might have increased over time. In that
case, the lack of change in mortality may have been due to the
improvements in preventive strategies, such as monitoring PSA. The
mortality rate due to tracheobronchial-lung cancer showed a major
decline over time; nevertheless, it remained the second leading cause
of death in this study. In general, smoking is the primary cause of lung
cancer; thus, our results indicated that smoking probably continued to
be an important public health problem in Mexico. In addition,
smoking, together with a fat-rich diet, a sedentary lifestyle, and an
overweight status, may have also contributed to the significant
increase over time in mortality due to colorectal cancer among men.
The decrease over time in mortality due to cervical cancer in overall
women has been also reported previously in others Mexican studies
[14] but not in woman ≥ 65 years. Programs for early detection of
precancerous lesions and improvements in treatment could explain
these results. Recently, HPV vaccinations have been included in
national vaccination campaigns [15]; therefore, this favorable
tendency towards decreasing mortality due to cervical cancer is likely
to continue in the future. Although different to our results, the recent
increase in breast cancer mortality of Mexican woman has been also
observed previously in woman ≥ 65 year-old [16]. These data
indicated that much effort is needed to reverse the significant increase
in mortality due to breast cancer. These efforts must include
promoting self-examination and providing mammography at an
accessible cost.
Conclusions
Compared to more developed countries, in Mexico, the mortality
due to cancer in older individuals is low, and it has exhibited a
significant decline over recent years. Men had a higher mortality rate
than women. Mortality due to colorectal-anal and breast cancer
subtypes significantly increased over time. In addition, mortality rates
due to breast and prostate cancer subtypes remain high in Mexico.
More studies in older individuals are needed in Mexico.
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